Integral Health Asset Management »

Amicus Therapeutics shares owned by Integral Health Asset Management

Quarter-by-quarter ownership of Amicus Therapeutics (FOLD) shares owned by Integral Health Asset Management from 13F filings

Historical chart of Integral Health Asset Management investment in Amicus Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Amicus Therapeutics held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amicus Therapeutics by Integral Health Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $4.9M 387k 12.56
2023-03-31 $3.4M 305k 11.09
2022-12-31 $4.0M 327k 12.21
2022-09-30 $1.4M 130k 10.44
2022-06-30 $7.6M 705k 10.74
2022-03-31 $2.1M 224k 9.47
2021-12-31 $2.0M 175k 11.55
2021-09-30 $4.1M 425k 9.55
2021-06-30 $4.6M 475k 9.64

More positions owned by Integral Health Asset Management

Insmed Com Par $.01 (INSM)
Cytokinetics Com New Call Option (CYTK)
Tenet Healthcare Corp Com New (THC)
Mineralys Therapeutics (MLYS)
Vera Therapeutics Cl A (VERA)
Uniqure Nv SHS (QURE)
Brightspring Health Svcs (BTSG)
Boston Scientific Corporation (BSX)
Newamsterdam Pharma Company Ordinary Shares Put Option (NAMS)
Regeneron Pharmaceuticals (REGN)
Alignment Healthcare (ALHC)
Alnylam Pharmaceuticals (ALNY)
Novartis Sponsored Adr (NVS)
Encompass Health Corp (EHC)
Edgewise Therapeutics (EWTX)

View all positions for Integral Health Asset Management

Top funds holding Amicus Therapeutics

Vanguard Group
Wellington Management Company
BlackRock
William Blair Investment Management
venBio Select Advisor
Millennium Management
State Street Corporation
Vestal Point Capital
Citadel Advisors
Point72 Asset Management
Geode Capital Management
Perceptive Advisors
UBS Group
Palo Alto Investors
Soleus Capital Management

View all funds holding Amicus Therapeutics